• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

施莱辛格做到了!评估噬菌体疗法中噬菌体的一项关键主要药效学特性:静止细菌靶点的病毒体相遇率。

Schlesinger Nailed It! Assessing a Key Primary Pharmacodynamic Property of Phages for Phage Therapy: Virion Encounter Rates with Motionless Bacterial Targets.

作者信息

Abedon Stephen T

机构信息

Department of Microbiology, The Ohio State University, Mansfield, OH 44906, USA.

出版信息

Drugs Drug Candidates. 2023 Sep;2(3):673-688. doi: 10.3390/ddc2030034. Epub 2023 Aug 18.

DOI:10.3390/ddc2030034
PMID:38770155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11104014/
Abstract

Bacteriophages (phages) are viruses of bacteria and have been used as antibacterial agents now for over one-hundred years. The primary pharmacodynamics of therapeutic phages can be summed up as follows: phages at a certain concentration can reach bacteria at a certain rate, attach to bacteria that display appropriate receptors on their surfaces, infect, and (ideally) kill those now-adsorbed bacteria. Here, I consider the rate at which phages reach bacteria, during what can be dubbed as an 'extracellular search'. This search is driven by diffusion and can be described by what is known as the phage adsorption rate constant. That constant in turn is thought to be derivable from knowledge of bacterial size, virion diffusion rates, and the likelihood of phage adsorption given this diffusion-driven encounter with a bacterium. Here, I consider only the role of bacterial size in encounter rates. In 1932, Schlesinger hypothesized that bacterial size can be described as a function of cell radius (, or ), as based on the non-phage-based theorizing of Smoluchowski (1917). The surface area of a cell-what is actually encountered-varies however instead as a function . Here, I both provide and review evidence indicating that Schlesinger's assertion seems to have been correct.

摘要

噬菌体是细菌病毒,作为抗菌剂已被使用了一百多年。治疗性噬菌体的主要药效学可总结如下:一定浓度的噬菌体能够以一定速率到达细菌,附着在其表面具有合适受体的细菌上,进行感染,并(理想情况下)杀死这些现已吸附的细菌。在此,我考虑在所谓的“细胞外搜索”过程中噬菌体到达细菌的速率。这种搜索由扩散驱动,可以用所谓的噬菌体吸附速率常数来描述。反过来,这个常数被认为可以从细菌大小、病毒体扩散速率以及在这种由扩散驱动的与细菌相遇情况下噬菌体吸附的可能性等知识推导出来。在此,我仅考虑细菌大小在相遇速率中的作用。1932年,施莱辛格假设细菌大小可以描述为细胞半径( ,或 )的函数,这是基于斯莫卢霍夫斯基(1917年)基于非噬菌体的理论。然而,细胞的实际被接触到的表面积却随 函数变化。在此,我既提供又审视证据,表明施莱辛格的断言似乎是正确的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a208/11104014/2d1486e3c381/nihms-1981836-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a208/11104014/fa15fb894409/nihms-1981836-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a208/11104014/b2191cc32553/nihms-1981836-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a208/11104014/a63946582f80/nihms-1981836-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a208/11104014/c2695b6739d3/nihms-1981836-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a208/11104014/2d1486e3c381/nihms-1981836-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a208/11104014/fa15fb894409/nihms-1981836-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a208/11104014/b2191cc32553/nihms-1981836-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a208/11104014/a63946582f80/nihms-1981836-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a208/11104014/c2695b6739d3/nihms-1981836-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a208/11104014/2d1486e3c381/nihms-1981836-f0005.jpg

相似文献

1
Schlesinger Nailed It! Assessing a Key Primary Pharmacodynamic Property of Phages for Phage Therapy: Virion Encounter Rates with Motionless Bacterial Targets.施莱辛格做到了!评估噬菌体疗法中噬菌体的一项关键主要药效学特性:静止细菌靶点的病毒体相遇率。
Drugs Drug Candidates. 2023 Sep;2(3):673-688. doi: 10.3390/ddc2030034. Epub 2023 Aug 18.
2
Bacteriophage Adsorption: Likelihood of Virion Encounter with Bacteria and Other Factors Affecting Rates.噬菌体吸附:病毒体与细菌相遇的可能性及影响速率的其他因素
Antibiotics (Basel). 2023 Apr 7;12(4):723. doi: 10.3390/antibiotics12040723.
3
Experimental Evolution of the TolC-Receptor Phage U136B Functionally Identifies a Tail Fiber Protein Involved in Adsorption through Strong Parallel Adaptation.通过功能鉴定 TolC 受体噬菌体 U136B 的实验进化,确定了一种与吸附作用相关的尾丝蛋白,这是通过强烈的平行适应实现的。
Appl Environ Microbiol. 2023 Jun 28;89(6):e0007923. doi: 10.1128/aem.00079-23. Epub 2023 May 16.
4
Automating Predictive Phage Therapy Pharmacology.自动化预测性噬菌体治疗药理学
Antibiotics (Basel). 2023 Sep 8;12(9):1423. doi: 10.3390/antibiotics12091423.
5
Phage and phage cocktails formulations.噬菌体和噬菌体鸡尾酒制剂。
Prog Mol Biol Transl Sci. 2023;200:159-169. doi: 10.1016/bs.pmbts.2023.04.007. Epub 2023 May 5.
6
Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?噬菌体 - 抗生素联合治疗:抗生素对噬菌体治疗药效学的拮抗作用?
Antibiotics (Basel). 2019 Oct 11;8(4):182. doi: 10.3390/antibiotics8040182.
7
Bacteriophage Adherence to Mucus Mediates Preventive Protection against Pathogenic Bacteria.噬菌体黏附黏液可预防致病菌感染。
mBio. 2019 Nov 19;10(6):e01984-19. doi: 10.1128/mBio.01984-19.
8
[Biological characteristics and genomic information of a bacteriophage against pan-drug resistant in a burn patient and its effects on bacterial biofilm].[烧伤患者中一株抗泛耐药菌噬菌体的生物学特性、基因组信息及其对细菌生物膜的影响]
Zhonghua Shao Shang Za Zhi. 2020 Jan 20;36(1):14-23. doi: 10.3760/cma.j.issn.1009-2587.2020.01.004.
9
A simple solid media assay for detection of synergy between bacteriophages and antibiotics.一种简单的固体培养基检测法,用于检测噬菌体和抗生素之间的协同作用。
Microbiol Spectr. 2024 May 2;12(5):e0322123. doi: 10.1128/spectrum.03221-23. Epub 2024 Mar 25.
10
Phage Therapy: The Pharmacology of Antibacterial Viruses.噬菌体疗法:抗菌病毒的药理学
Curr Issues Mol Biol. 2021;40:81-164. doi: 10.21775/cimb.040.081. Epub 2020 Jun 6.

引用本文的文献

1
Evaluating phage lytic activity: from plaque assays to single-cell technologies.评估噬菌体裂解活性:从噬菌斑测定到单细胞技术。
Front Microbiol. 2025 Aug 29;16:1659093. doi: 10.3389/fmicb.2025.1659093. eCollection 2025.
2
Highly stable bacteriophages PIN1 and PIN2 have hallmarks of flagellotropic phages but infect immotile bacteria.高度稳定的噬菌体PIN1和PIN2具有鞭毛嗜性噬菌体的特征,但能感染不能运动的细菌。
Npj Viruses. 2025 Jul 16;3(1):56. doi: 10.1038/s44298-025-00139-4.
3
Microscopic phage adsorption assay: High-throughput quantification of virus particle attachment to host bacterial cells.

本文引用的文献

1
Translating phage therapy into the clinic: Recent accomplishments but continuing challenges.将噬菌体疗法转化为临床应用:近期的成就与持续的挑战。
PLoS Biol. 2023 May 23;21(5):e3002119. doi: 10.1371/journal.pbio.3002119. eCollection 2023 May.
2
Bacteriophage Adsorption: Likelihood of Virion Encounter with Bacteria and Other Factors Affecting Rates.噬菌体吸附:病毒体与细菌相遇的可能性及影响速率的其他因素
Antibiotics (Basel). 2023 Apr 7;12(4):723. doi: 10.3390/antibiotics12040723.
3
Phage therapy: From biological mechanisms to future directions.
微观噬菌体吸附测定:病毒颗粒与宿主细菌细胞附着的高通量定量分析。
Proc Natl Acad Sci U S A. 2024 Dec 24;121(52):e2410905121. doi: 10.1073/pnas.2410905121. Epub 2024 Dec 19.
4
Genetic variation in individuals from a population of the minimalist bacteriophage Merri-merri-uth nyilam marra-natj driving evolution of the virus.来自极简噬菌体Merri-merri-uth nyilam marra-natj群体的个体中的基因变异推动了病毒的进化。
mBio. 2024 Dec 11;15(12):e0256424. doi: 10.1128/mbio.02564-24. Epub 2024 Oct 30.
噬菌体疗法:从生物学机制到未来方向。
Cell. 2023 Jan 5;186(1):17-31. doi: 10.1016/j.cell.2022.11.017.
4
Further Considerations on How to Improve Phage Therapy Experimentation, Practice, and Reporting: Pharmacodynamics Perspectives.关于如何改进噬菌体治疗实验、实践及报告的进一步思考:药效学视角
Phage (New Rochelle). 2022 Jun 1;3(2):98-111. doi: 10.1089/phage.2022.0019. Epub 2022 Jun 16.
5
Recent progress toward the implementation of phage therapy in Western medicine.近年来,噬菌体疗法在西方医学中的应用取得了进展。
FEMS Microbiol Rev. 2022 Jan 18;46(1). doi: 10.1093/femsre/fuab040.
6
On Phage Adsorption to Bacterial Chains.关于噬菌体对细菌链的吸附
Biophys J. 2020 Nov 3;119(9):1896-1904. doi: 10.1016/j.bpj.2020.09.027. Epub 2020 Sep 29.
7
Bacterial Biofilm and its Role in the Pathogenesis of Disease.细菌生物膜及其在疾病发病机制中的作用
Antibiotics (Basel). 2020 Feb 3;9(2):59. doi: 10.3390/antibiotics9020059.
8
Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.药理认知噬菌体治疗:噬菌体抗细菌作用在动物和人体中的药效学和药代动力学障碍。
Microbiol Mol Biol Rev. 2019 Oct 30;83(4). doi: 10.1128/MMBR.00012-19. Print 2019 Nov 20.
9
Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review.噬菌体治疗:哪些因素影响噬菌体的药代动力学和生物利用度?系统评价和批判性综述。
Med Res Rev. 2019 Sep;39(5):2000-2025. doi: 10.1002/med.21572. Epub 2019 Mar 19.
10
A growing microcolony can survive and support persistent propagation of virulent phages.一个不断生长的微菌落可以存活并支持毒性噬菌体的持续繁殖。
Proc Natl Acad Sci U S A. 2018 Jan 9;115(2):337-342. doi: 10.1073/pnas.1708954115. Epub 2017 Dec 19.